Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
-

Cipro I.V. (ciprofloxacin) For Intravenous Infusion


Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- January 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary.


Summary View

Sections Modified

PRECAUTIONS

  • Photosensitivity/Phototoxicity
    • Moderate to severe photosensitivity/phototoxicity reactions, the latter of which may manifest as exaggerated sunburn reactions...
  • Information for Patients
    • Patients should be advised: that photosensitivity/phototoxicity has been reported in patients receiving quinolones...

ADVERSE REACTIONS

  • Skin/Hypersensitivity
    • Photosensitivity/Phototoxicity Reaction
  • Postmarketing Adverse Events
    • Photosensitivity/Phototoxicity Reaction

 

 

-
-